Hypercalcemic nephropathy.
Benabe JE, Martinez-Maldonado M.
Arch Intern Med. 1978 May;138(5):777-9.
Secondary and Tertiary Hyperparathyroidism.
Messa P, Alfieri CM.
Front Horm Res. 2019;51:91-108. doi: 10.1159/000491041. Epub 2018 Nov 19.
Familial hypocalciuric hypercalcemia and related disorders.
Lee JY, Shoback DM.
Best Pract Res Clin Endocrinol Metab. 2018 Oct;32(5):609-619. doi: 10.1016/j.beem.2018.05.004. Epub 2018 May 26.
[Hypercalcemic nephropathy].
Makino H, Kawabata K, Mimura Y.
Ryoikibetsu Shokogun Shirizu. 1997;(17 Pt 2):193-6.
Hypercalcemic nephropathy.
NASH DT, SCHWARTZ BM.
J Mt Sinai Hosp N Y. 1958 Sep-Oct;25(5):458-63.
Normocalcemic Hyperparathyroidism.
Corbetta S.
Front Horm Res. 2019;51:23-39. doi: 10.1159/000491036. Epub 2018 Nov 19.
[Hypercalcemic crisis and hypocalcemic tetany].
Kasperk C.
Internist (Berl). 2017 Oct;58(10):1029-1036. doi: 10.1007/s00108-017-0311-3.
HYPERCALCAEMIC NEPHROPATHY.
PARFITT AM.
Med J Aust. 1964 Jul 25;2:127-34. doi: 10.5694/j.1326-5377.1964.tb115035.x.
[Hypercalcemic nephropathy].
MORTENSEN ES.
Ugeskr Laeger. 1961 Jun 16;123:833-8.
Management of normocalcemic primary hyperparathyroidism.
Cusano NE, Cipriani C, Bilezikian JP.
Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):837-845. doi: 10.1016/j.beem.2018.09.009. Epub 2018 Sep 28.
